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Key Question: How does the nature of the pulmonary vasculature impact on 
technique and survival in pulmonary atresia/VSD/MAPCAs? 
 
Key Findings: Unifocalisation can be achieved in 90% of cases but the need to 
leave VSD open is associated with poorer late survival 
 
Take-Home Message: Combination of Rehabilitation and Recruitment Strategy  
achieves high unifocalisation rates 
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Abstract:  2 
Objectives: To define the early and late outcomes of unifocalisation based on a 3 
classification of the native pulmonary artery(nPA) system and Major Aortopulmonary 4 
Collateral Arteries(MAPCAs) with a policy of combined recruitment and rehabilitation. 5 
To analyse the role of unifocalisation leaving the VSD open with a limiting right 6 
ventricle-pulmonary artery conduit in borderline cases. 7 
Methods: Analysis of 271 consecutive patients assessed for unifocalisation at a single 8 
institution between 1988-2016. Patients classified according to the pulmonary blood 9 
supply: Group A, unifocalisation based on nPA only; Group B, based on nPA and 10 
MAPCAs; Group C, MAPCAs only(absent nPAs). 11 
Results: Unifocalisation was achieved in 249(91.9%) cases with an early mortality of 12 
2.8%. Group A included 72(28.9%) patients, Group B 119(47.8%) patients and Group 13 
C 58(23.3%) patients with no difference in early survival between groups. Survival at 14 
5, 10 and 15 years was 90.0%(85.9 to 94.3), 87.2%(83.5 to 91.2) and 82.3%(75.2 to 15 
89.9). Late survival in Groups A and B was similar but 10 and 15 year survival in 16 
Group C was decreased at 79.2%(68.2 to 92.1) and 74.3%(61.1 to 90.4) (p=0.02). A 17 
mean of 1.9(±0.6) MAPCAs were recruited per patient (range 0-6). 18 
The VSD was left open with a limiting RV-PA conduit in 97(39.0%) cases, but 19 
subsequently closed in 48, giving, a total of 200(80.3%) achieving VSD closure(full 20 
repair). Delaying VSD closure was not associated with increased risk for early or late 21 
survival. 22 
A central shunt to rehabilitate the nPAs was used in 56(22.5%) cases. This was 23 
associated with a reduction in the number of MAPCAs recruited, but still required a 24 
mean of 1.8(±0.5) MAPCAs recruited per patient to achieve unifocalisation. 25 
In multivariate risk analysis, those suitable for single stage full repair had the best long 26 
term outcomes. Group C anatomy was associated with poor late survival compared to 27 
Groups A and B (hazard ratio2.7). 28 
Conclusion: Survival is maximized by a combined approach of rehabilitation and 29 
recruitment. MAPCAs should always be recruited if they supply areas with absent nPA 30 
supply. A strategy of leaving the VSD open with a limiting RV-PA conduit is a safe and 31 
effective way of managing borderline cases. 32 
  33 
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Introduction 34 
 35 
Pulmonary atresia with ventricular septal defect(VSD) and major aortopulmonary collateral 36 
arteries(MAPCAs) is a complex and rare (10 of 100,000 livebirths[1]) condition, 37 
characterized by a heterogeneity of pulmonary blood flow derived from multiple sources 38 
that vary in number, size, distribution and origin, as well a variable relationship between the 39 
MACPAs themselves and the native pulmonary artery(nPA) system[2-4]. This great 40 
variability means that a single strategy or technique will not suit all patients, but the 41 
importance of ‘unifocalisation’ of all pulmonary blood flow to a central source has become 42 
widely accepted as the primary goal.  43 
 Surgical strategies are evolving that have dramatically improved the prognosis– but there 44 
remains controversy regarding the ideal approach to achieve the best long-term outcomes. 45 
 46 
This study addressed three key areas of this controversy:  (a) having achieved 47 
unifocalisation, when should the VSD be left open or closed, (b) the relative contribution of 48 
MAPCAs versus native PAs in achieving unifocalisation, (c) the role of rehabilitating native 49 
PAs prior to unifocalisation. There also continue to be differing opinions over specifics of 50 
surgical technique such as sternotomy alone verses sternotomy and thoracotomy [5,6]. One 51 
philosophy of management is to rely predominantly on native PAs alone but the majority of 52 
reports (including our own) favour recruitment of MAPCAs wherever possible, in tandem 53 
with the native vessels [7]. Key to this strategy is the recognition of the concept of ‘dual 54 
supply’ where the same region of pulmonary vascular bed is supplied by both the nPA 55 
system and by MAPCAs. 56 
 57 
Materials and Methods 58 
 59 
Data on all patients with pulmonary atresia, VSD and MAPCAs who underwent surgical 60 
intervention at Birmingham Children’s Hospital, United Kingdom, between January 1988 and 61 
December 2016, were reviewed. Angiograms and operative details were available for all 62 
patients and hospital records for all interventions and follow-up. Patients referred from 63 
overseas (12%) were followed up locally, with current status obtained for 98% of cases. The 64 
study was registered with our institutional Research & Development office; in accordance 65 
with the UK NHS National Research Ethics Service guidance, neither individual informed 66 
consent nor formal Research Ethics Committee review was required, because the study was 67 
undertaken using information previously collected in the course of routine care. 68 
 69 
Patients with other intra-cardiac pathologies accompanied by MAPCAs were excluded from 70 
the study. A total of 271 patients were included, of which 53(19.6%) patients had been 71 
referred to us after initial palliation in a different centre.  72 
Assessment: All patients underwent extensive angiography including pulmonary vein wedge 73 
injections followed by CT angiography or MRI to define the three-dimensional anatomy and 74 
the relationship to the airways and oesophagus (Our institutional preference is for CT angio 75 
but MRI can be used especially if functional information on the heart is required). A 76 
roadmap of the pulmonary vasculature was created, establishing the origin, size and 77 
distribution of each MAPCA as well as the presence, size and extent of any native PAs. It was 78 
particularly important to identify areas of the lung with dual supply. 79 
 80 
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The primary aim was to achieve unifocalisation of all accessible pulmonary vessels at a 81 
single stage. Native PAs were used wherever possible but all MAPCAs supplying one or more 82 
segments of the lung were recruited as part of the surgical strategy, unless there was clear 83 
evidence of dual supply (in which case they were ligated). The lung fields were divided into 84 
their 20 broncho-pulmonary segments and operative strategy was to close the VSD if 15 or 85 
more lung segments could be recruited. This involved careful assessment of all AP and 86 
lateral injections of each MAPCA to create as accurate an estimate as possible.  If <15 could 87 
be recruited then the VSD was left open - placing a limiting RV-PA conduit to prevent 88 
overcirculation.  If vessels were found to be of poorer quality than expected at time of 89 
surgery, or if MAPCAs could not be accessed, then the strategy reverted to leaving the VSD 90 
open. We prefer this to leaving a fenestrated VSD, which can be difficult to judge if the 91 
pulmonary vascular resistance changes over the early post-operative period. 92 
 93 
The unifocalisation strategy was categorized into 3 groups defined as follows:: 94 
Group A – unifocalisation based on native PAs only,  95 
Group B – unifocalisation with a combination of native PAs and MAPCAs  96 
Group C – unifocalisation with MAPCAs only i.e. absent native PAs. 97 
 98 
Patients presenting with confluent but small/diminutive central PAs and MAPCAs that were 99 
inadequate to achieve the target of 15/20 perfused segments underwent creation of an AP 100 
window to drive antegrade flow into these vessels (sometimes referred to as the 101 
‘Melbourne Shunt’ as described by Watterson et al [8]).  These patients subsequently fell 102 
into groups A and B, and the use of this central shunt/AP window was factored into the 103 
analysis. Wherever possible, these central shunts were performed without bypass, but if the 104 
aorta did not tolerate the necessary partial clamping and distortion, then bypass was used 105 
to provide stability. 106 
 107 
Surgical approach: The technical aspects of our approach to unifocalisation have been 108 
described previously and can be summarized as follows (figs 1 and2)[9-11]: The preferred 109 
approach was midline sternotomy alone. However, initial thoracotomy was used when 110 
access to MAPCAs from the midline was likely to be difficult or if MAPCA  anastomosis(es) 111 
could be better performed via thoracotomy. 112 
 113 
At sternotomy, all vessels were mobilised and controlled, often working through the 114 
posterior pericardium between the aorta and SVC to develop vessels lying under the carina 115 
and along the underside of the main bronchi.  Cardiopulmonary bypass was established and 116 
the origins of all MAPCAs ligated. Vessels were controlled distally with Yasargil® clips, 117 
divided at their origins and laid open along their length to reach maximum calibre. Native 118 
PAs were laid open out onto their branches to create a ‘platform’ of native tissue onto 119 
which the individual MAPCAs were attached. If no native PAs were present then larger 120 
MAPCAs were brought together across the midline to create this platform. The 121 
reconstructed platform of focalized vessels was then patched over with a large piece of 122 
pulmonary homograft(with separate patches into individual vessels if necessary). In Group A 123 
the feeding MAPCA vessels were ligated and the repair was based on the native PAs, which 124 
were laid open from hilum-to-hilum, and out into their branches if necessary before being 125 
reconstructed as above. 126 
 127 
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A defect was then cut into the homograft patch to receive the RV-PA conduit. Conduits used 128 
were either aortic homografts or Hancock® valved tube grafts. If there was inadequate 129 
tissue across the midline, ipsilateral vessels were focalized at each hilum and then patched 130 
together with pulmonary homograft; a Goretex® tube graft was then used to connect these 131 
two sets of vessels together and the RV-PA conduit connected to this tube as a T-graft.  132 
 133 
 If the VSD was to be left open, then limiting conduits were selected at a diameter to be the 134 
predicted half-size +2mm based on the patients’ body surface area. If necessary these could 135 
be externally clipped with ligaclips to limit the intraluminal diameter to the desired point. 136 
Dacron valved conduits were used as these could be sure to maintain their dimensions 137 
under high pressure. Our techniques share common features of repairs reported by other 138 
centres[5,12]. 139 
 140 
Statistical methods: 141 
 142 
Data are presented as counts and percentages or for continuous values as median and 143 
interquartile range (Q1-Q3). Demographic characteristics were compared using the 144 
Kruskall–Wallis test or the Chi-Square test. 145 
Short-term mortality is calculated based on status at 30-days post repair. Estimates of 146 
survival were made using the Kaplan–Meier method, using mortality as the event. Survival 147 
between groups was compared using the log-rank test. A Cox PH model was created to look 148 
at risk factors for mortality. The age at repair over time is presented as a Locally Estimated 149 
Scatterplot Smoother (LOESS) plot. 150 
Statistical analyses were performed with R version 3.5.1 (R Core Team, 2018). 151 
 152 
Results 153 
 154 
A total of 271 consecutive patients were included in the study. Unifocalisation was achieved 155 
in 249(91.9%) of cases(table 1). The remaining 22(8.1%) cases either had such poor 156 
vasculature that they were not suitable for unifocalisation(18, 6.6%) or are currently 157 
awaiting planned unifocalisation(4, 1.5%). These patients have been palliated with shunts 158 
and/or stents to individual vessels.  159 
 160 
  Group A – unifocalisation was based on native PAs only(72, 28.9%),  161 
  Group B – unifocalisation based on a combination of native PAs and MAPCAs(119, 47.8%) 162 
  Group C – unifocalisation using MAPCAs only(58, 23.3%). 163 
 164 
A total of 789 MAPCAs were defined in the group of 249 cases, in which a mean of 1.9(±0.6) 165 
MAPCAs were recruited per patient (ranging from 0 to 6). A total of 268 MAPCAs were 166 
ligated at the time of surgery due to there being dual supply. The numbers of MAPCAs 167 
recruited and ligated are summarised in table 2. When comparing Groups B and C, 168 
significantly more MAPCAs were recruited per patient in Group C(p=0.01), but the ratio of 169 
recruited:ligated MAPCAs was similar in both groups (p=0.57). 170 
 171 
The median age of patients at time of unifocalisation in the entire study was 23 months. 172 
There was no statistical difference in mean age across the three groups, although those in 173 
Group C were the youngest, at a median of 18 months. The median age at unifocalisation 174 
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has reduced over the period of the study, having been 44.3 months in the initial quartile and 175 
18.0 months in the last quartile(table 1). A LOESS line plot depicting the distribution of ages 176 
of the entire series is provided in the supplementary data(Supplementary Fig.1). 177 
 178 
In terms of the surgical approach used, 91(36.5%) patients were unifocalised utilising 179 
median sternotomy alone and 158(64% patients) using combined thoracotomy and median 180 
sternotomy. There was no difference in survival at 5, 10 or 15 years between these two 181 
groups(p=0.58).  182 
 183 
Early (30 day and in-hospital) mortality was 2.8%(7 patients) with no early deaths in the last 184 
12 years of the study. Survival of the entire group is shown in figure 3a with 5, 10 and 15 185 
year survival of 90.0%(85.9 to 94.3), 87.2%(83.5 to 91.2) and 82.3%(75.2 to 89.9). There was 186 
no difference in early survival between the three groups(table 1, p=0.10). Kaplan-Meier 187 
survival curves for the three groups of patients in shown in figure 3b.  Survival of Groups A 188 
and B were very similar and the combined A and B patients had a 10 and 15 year survival of 189 
89.6% (84.1 to 95.6) and 84.7% (76.6 to 93.7). However, late survival of Group C 190 
patients(absent native PAs) was significantly worse than Groups A and B combined, with 10 191 
and 15 year survival of 79.2%(68.2 to 92.1) and 74.3%(61.1 to 90.4) (p=0.02). 192 
 193 
Central (‘Melbourne’) shunt:  By definition, these patients were all in Groups A and B. A total 194 
of 56(22.5%) patients underwent a central shunt, with 45(80.4%) in Group B and 11(19.6%) 195 
in Group A.  Figure 4 shows the outcomes of unifocalisation in patients who required initial 196 
central (Melbourne) shunt verses those undergoing single stage repair with no difference in 197 
early or late survival between the groups(p=0.62). Within Group B, the mean number of 198 
recruited MAPCAs was 1.8(±0.5) in the Melbourne-shunt patients compared to 2.5(±0.7) 199 
who had single stage unifocalisation. The ratio of recruited: ligated MAPCAs was 2.05 in the 200 
Melbourne-shunt group compared to 2.75 in the single-stage group(p=0.05).  201 
 202 
Status of the VSD: open or closed:  The VSD was closed at the primary procedure in 203 
152(61.0%) cases. The corollary of this is that the VSD was left open with a limiting conduit 204 
in 97 (39.0%) patients, in whom, the VSD was subsequently closed at a second procedure 205 
(‘delayed VSD closure’) in 48 of the 97(49.5%). Overall, a total of 200(80.3%) cases achieved 206 
VSD closure (full repair) during the period of this study. 207 
In the analysis of the remaining 51 patients, complete repair is predicted in a further 8 208 
cases. This leaves 43(17.3% of the total cohort) cases where the vasculature is felt to never 209 
be suitable for VSD closure and this is likely to be their final status. 210 
 211 
There was no difference in early mortality between the group in whom full repair was 212 
achieved and those in whom the VSD was left open. The VSD was left open initially in 29% of 213 
Group A patients compared to 43% in Group B and 38% in Group C (p=0.13). There was also 214 
no difference in the frequency of VSD closure between Groups A, B or C (table 1). There 215 
were two patients in whom the VSD was initially closed, but had to be fenestrated within 216 
the first 24 hours due to high RV pressures. One of these patients was an early death with 217 
progressive heart failure and the second was able to have the VSD fully closed at a 218 
subsequent procedure. 219 
 220 
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Survival curves according to VSD status are shown in figure 5(a and b). Patients in whom the 221 
VSD has never been closed had a significantly worse survival of 75.3%(71.5 to 79.0) at 10 222 
years and 60.5%(54.5 to 67.8) at 15 years compared to patients in whom the VSD was 223 
closed. There was no difference in the late survival for the groups in whom the VSD was 224 
closed at the primary operation or at a subsequent procedure(figure 5a).  This is 225 
summarised in figure 5b where all patients who achieved VSD closure are grouped together 226 
verses those that have the VSD left open. This shows a clear survival benefit in those 227 
patients in whom the VSD is closed, with a 10 year survival of 93.0% and 15 year survival of 228 
91.0%(p=0.003). 229 
 230 
On multivariate analysis of risk factors(table 3), Group C anatomy had the greatest hazard 231 
for late mortality at 2.76. Cases suitable for single stage full correction carried the lowest 232 
hazard for late survival. The use of an AP window/Melbourne Shunt carried a slightly greater 233 
hazard (HR 1.46) than those undergoing single stage repair. In analysis of the number of 234 
MAPCAs that had to be recruited, the need to recruit ≥4 MAPCAs was associated with 235 
increased risk(HR 1.6) compared to those in whom ≤2 MAPCAs had to be recruited. 236 
 237 
 238 
 239 
Discussion 240 
 241 
This study has focused on a practical classification of patients according to the nature of 242 
their pulmonary blood supply – from native PAs, from MAPCAs or from a mixture of the 243 
two, recognizing that some areas of the lung have ‘dual supply’ from a MAPCA that feeds 244 
into a native PA system. Just under one half of the patients have a combination of native 245 
PAs and MAPCAs, with about one quarter having native vessels only (dual supplied by 246 
MAPCAs). The remaining cases (about one quarter) have absent native vessels and the 247 
pulmonary blood supply is exclusively from MAPCAs. Our philosophy is that unifocalisation 248 
should utilize both PAs and MAPCAs and can be achieved in close to 90% of all patients 249 
regardless of the classification, with very low early mortality. However, the latter group tend 250 
to have overall poorer vasculature and poorer long-term survival.  251 
 252 
Although different strategies have been proposed around the world, common themes of 253 
early unifocalisation are increasingly favoured and the results of this series suggest that 254 
excellent outcomes can be achieved with a strategy of maximal recruitment of pulmonary 255 
vasculature and the establishment of RV-PA continuity. The use of using a limiting RV-PA 256 
conduit and leaving the VSD open is a successful means of managing the borderline cases.  257 
This study shows, in keeping with the Stanford group, that unifocalisation can be achieved in 258 
the majority of patients [13,14]. Those in whom this cannot be achieved are the worst end 259 
of the spectrum with poor vasculature and progressive cyanosis - probably 10-15% of all 260 
patients will fall into this group [9,13]. 261 
Earlier assessment and unifocalisation has been strongly advocated by the Stanford group 262 
[16] and is supported by this study. The median ages of the patients in our study was older 263 
than in the Stanford series (partly skewed by the proportion of much older children referred 264 
from outside our centre), but is steadily reducing and we would advocate early assessment 265 
and unifocalisation at 6-9 months wherever possible. 266 
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Careful assessment of the pulmonary vasculature at an early stage is paramount to the 267 
success of this strategy. Areas of the lung with unprotected high flow can develop 268 
pulmonary vascular disease, whereas other areas can be supplied by MAPCAs in which the 269 
proximal course is progressively stenosed (or even occluded). Early recruitment secures 270 
antegrade flow into the vascular bed and promotes growth.  271 
 272 
This study supports the ‘recruitment’ philosophy of incorporating both native PAs and the 273 
MAPCAs into unifocalisation to achieve best outcomes. Some authors have favoured an 274 
alternative approach to focus on the native PA vessels only, excluding (and ligating ) 275 
MAPCAs wherever possible, which is referred to as a ‘rehabilitation strategy’ [6,7].  Clearly, 276 
such a strategy is not feasible in the 15-20% of patients who have complete absence of 277 
native PA vessels(Group C) and, furthermore, we have shown that even in patients with a 278 
native PA system, some areas of the lung may have sole supply from MAPCAs that should be 279 
recruited. ‘Rehabilitation alone’ approaches report an ability to achieve repair in 60-280 
73%[6,7,18], compared to 80% in our series and close to 90% in the Stanford series with 281 
outstanding results and low RV pressures[13,15,16]. Thus, although there is no doubt that 282 
the overall quality of native PAs is generally better than that of MAPCAs, the importance of 283 
MAPCA recruitment is crucial to success. Furthermore, the series that utilize native PAs 284 
alone report early mortality of 10% and more than half the patients had an RV pressure of 285 
>50% systemic at completion. 286 
 287 
The intrinsic superiority of utilizing native PAs is supported by the finding that the long-term 288 
outcomes of Group A and B in this study were better than those of Group C. Nevertheless, 289 
there was no difference in early outcomes between all groups and the late survival of 80% 290 
was still achieved at 10 years in Group C, which have traditionally been the most challenging 291 
group to manage.  We utilized the Melbourne shunt in about one third of patients in Group 292 
A and B. None of these patients were felt to be suitable for unifocalisation at initial 293 
presentation, yet the outcomes ultimately achieved for this group were the same as those 294 
who underwent single stage repair. Although the shunt was not necessary in the majority of 295 
patients, it is an invaluable interim step in the particular group of patients with small native 296 
PAs that have good distribution to the lungs. Nevertheless,  it was important to note that 297 
whilst recruitment of additional MAPCAs was reduced, it remained an essential part of 298 
repair even the patients who responded well to the Melbourne shunt (mean of 1.8 MAPCAs 299 
per patient). This is the clear benefit of the ‘rehabilitation’ strategy and the results of this 300 
study suggest that best outcomes are achieved by combining the advantages of both 301 
rehabilitation and recruitment into a combined approach. 302 
 303 
We have maintained a degree of flexibility over whether or not to close the VSD at the time 304 
of unifocalisation. Many authors describe the use of intra-operative flow studies to be a 305 
successful discriminator for VSD closure, calculating 3l.min-1.m-2 and accepting pressures of 306 
≤25mmHg (Stanford[14]) or  a protocol of 2.5l.min-1.m-2 with pressures of ≤30mmHg 307 
(Toronto[18]) and both groups have reported excellent results. We prefer to make an 308 
assessment based on the quality of the vasculature at pre-operative imaging and use the 309 
criterion of aiming to recruit ≥15/20 broncho-pulmonary segments. We feel that this works 310 
well with our philosophy of leaving the VSD open and placing a limiting (restrictive) RV-PA 311 
conduit in cases who fail to meet this threshold – other authors prefer a central shunt into 312 
the unifocalised vessels in this situation. The benefit of an RV-PA conduit is that it will be 313 
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delivering predominantly desaturated blood into the lungs and provide pulsatile flow - 314 
which provides optimal oxygen-delivery: flow ratio and a good stimulus for growth. The RV-315 
PA conduit also allows the surgeon more flexibility, as it can be externally clipped or 316 
released to balance flow at completion of surgery, and provides good access for subsequent 317 
catheterization. Intra-operative flow studies can be difficult to perform accurately in our 318 
experience and borderline values make decision-making difficult. An important finding to 319 
support this approach is that delaying VSD closure does not impair long-term outcomes, 320 
with similar long-term survival for all cases who achieve complete repair, whether this is in a 321 
single stage or at a subsequent procedure.  The overall approach to assessment and 322 
management is summarised  in supplementary figure 2. 323 
The patients in whom the VSD can never be closed are, by definition, those with poorer 324 
quality pulmonary vasculature and we feel these are more safely managed in this manner. 325 
The use of a restrictive RV-PA conduit provides a balanced circulation and avoids the RV 326 
being exposed to supra-systemic pressures. This arrangement can allow for a good quality of 327 
life in this more challenging group of patients. 328 
 329 
In conclusion, a combined approach of rehabilitation and recruitment is recommended. 330 
Preliminary central shunts improve native PA growth but do not preclude the need to 331 
recruit MAPCAs. Patients with absent native PAs achieve good early outcomes but are at 332 
risk of decreased late survival. Our goal is always early unifocalisation, but it is safe to leave 333 
the VSD open and use a limiting RV-PA conduit as a valuable interim measure. Borderline 334 
patients can undergo subsequent complete repair with long term outcomes that are similar 335 
to those undergoing primary repair. 336 
 337 
Limitations of the Study: The study focuses on unifocalisation and so contains only limited 338 
information on the small group in whom unifocalisation could never be achieved – this 339 
group of patients have the worst quality vasculature and much more guarded outcomes. 340 
Also, almost 20% of patients had been referred from outside institutions and so did not 341 
have a uniform approach from birth – often being much older at initial assessment. The 342 
study does not include uniform measurement of RV:LV pressure ratios at complete repair as 343 
these were not available for all patients. The long time period of the study cannot exclude 344 
an era effect, although no difference in outcomes by era could be demonstrated. 345 
 346 
 347 
 348 
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Figures: 
 
 
Figure 1. Unifocalization of a case with a combination of native pulmonary arteries (supplied by 
a single MAPCA, dual supply) and one area of the lung supplied by a MAPCA alone (left upper 
lobe). The MAPCA is recruited into the reconstructed native pulmonary arteries which are then 
connected to the right ventricle with a valved Dacron conduit. 
 
 
 
Figure 2. Unifocalisation in a case with four large MAPCAs but absent native central pulmonary 
arteries. The MAPCAs are disconnected from their origins, mobilized and brought together 
across the midline to create a platform. This confluence of vessels is then patched and 
connected to the right ventricle with a valved Dacron conduit. 
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Figure 3. Kaplan-Meier Plot showing actuarial survival of 249 patients undergoing unifocalization 
of pulmonary atresia with VSD and MAPCAs. (a) Entire Population, (b) Survial by group 
according to pulmonary artery morphology [from Barron et al. 11]. 
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Figure 4. Kaplan-Meier survival curve according to use of a ‘Melbourne’ central shunt prior to 
complete repair. 
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Figure 5.  Kaplan-Meier survival curves according to timing of VSD closure in PA/VSD/MAPCAs. 
(a) Survival in groups according to those in whom VSD was closed at initial surgery, at 
subsequent surgery or never been closed.  (b) Survival in groups according to whether the VSD 
left open or closed (either at initial or at subsequent surgery) [from Barron et al. 11] 
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Supplementary Figure 1: LOESS (Locally Estimated Scatterplot Smoother) plot showing variation 
in age at repair over the time period of the study 
 
Supplementary Figure 2: Summary of management strategies for patients with PA/VSD/MAPCAs 
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Table 1. Demographics of patients undergoing unifocalisation (n=249). 
 
 
 
 Overall 
(n=249) 
Native PAs only 
(Gp A, n=72) 
Native PAs + MAPCAs 
(Gp B, n=119) 
Any native PAs  
(Gps A+B, n=191) 
MAPCAs only 
(Gp C, n=58) 
p value 
(A/B/C) 
Age, months(median IQR) 23 (11-61) 26 (16 to 62) 21 (11 to 65) 24 (13 to 64) 18 (9 to 39) 0.12 
Male, n (%) 109 (43.8) 34 (47.2) 48 (40.3) 82 (42.9) 27 (46.6) 0.58 
DiGeorge, n (%) 72 (28.9) 16 (22.2) 34 (28.6) 50 (26.2) 22 (37.9) 0.14 
Single-stage repair, n (%) 111 (44.6) 22 (30.6) 56 (47.1) 78 (40.8) 33 (56.9) 0.01 
MAPCAs  (median (Q1-Q3) 3 (2 to 4) 3 (2 to 3) 3 (3 to 4) 3 (2 to 4) 3 (2 to 4) - 
MAPCAs  (mean, SD) 3.11 (1.25) 2.46 (1.09) 3.39 (1.23) 3.04 (1.26) 3.34 (1.19) <0.001 
Delayed VSD closure, n(%) 94 (37.8) 21 (29.2) 51 (42.8) 72 (37.6) 22 (37.9) 0.13 
VSD left open, n (%) 51 (20.5) 13 (18.1) 26 (21.8) 39 (20.4) 12 (20.7) 0.82 
30-day mortality, n (%) 7 (2.8) 1 (1.4) 2 (1.7) 3 (1.6) 4 (6.9) 0.10 
 
* Change in median age by era, divided into quartiles (median,Q1-Q3):   q1   44.3 (30.1-83.5) months 
              q2   24.2 (9.7-71.3) months 
              q3   18.0 (9.1-50,6) months 
               q4   18.1 (8.7-26.2) months 
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Table 2. Use of central shunt and the number and destiny of MAPCAs by group. 
 
Group n Initial 
central 
shunt 
Total 
MAPCAs 
No./case 
MAPCAs 
recruited 
no./case 
MAPCAs 
ligated  
no./case 
Native PAs only (A) 72 
(28.9%) 
11/72 
(15.3%) 
180  
(2.5±1.1) 
0 142 
(2.7±1.2) 
Native PAs + MAPCAs 
(B) 
119 
(47.8%) 
45/119 
(37.8%) 
406 
(3.4±1.2) 
286 
(2.4±1.3) 
109 
(1.9±1.0) 
MAPCAs only (C) 58 
(23.4%) 
0 200 
(3.4±1.2) 
188 
(3.3±1.2) 
13    
(0.2±0.6) 
 
MAPCAs, major aortopulmonary collateral arteries; PAs, pulmonary arteries. 
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Table 3: Hazard ratios for survival on multivariate analysis  
 
Factor 
Hazard 
ratio 
Lower 0.95 
CI 
Upper 0.95 
CI 
Number of MAPCAs (4 compared to 2) 1.62 0.89 2.96 
Group A-Native : Group B-Native & MAPCAs 1.00 0.34 2.94 
Group C-MAPCAs only :Group  B-Native & MAPCAs 2.76 1.08 7.08 
Melbourne shunt - yes:no 1.46 0.47 4.53 
One stage repair - yes:no 0.45 0.18 1.11 
 
Wald statistic for overall model 11.5 with 5 degrees of freedom, P = 0.04. 
 
 
